Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.
Open Access
- 1 August 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 98 (3) , 731-740
- https://doi.org/10.1172/jci118845
Abstract
To investigate the association of antigen specific CD4 T cell activation with HIV disease progression and AIDS-related central nervous system damage, T cell proliferation responses to HIV, CMV, and HSV were evaluated in infected individuals. CD4 T cell loss and neurocognitive impairment were assessed at 6-mo intervals. Individuals with known times of seroconversion who responded to more HIV peptides were at greater risk of progressing to < 200 CD4 T cells (P = 0.04) and dying (P = 0.03) than those with responses to fewer peptides. A positive correlation (0.52) was seen between the breadth of the HIV proliferation response and HIV plasma RNA levels. Higher proliferation responses to CMV and HSV were also associated with more rapid CD4 loss (P = 0.05). HLA phenotyped individuals (n = 150) with two HLA-DR alleles associated with response to more HIV peptides and CMV (DR-2,5,w6,10) were less likely to develop neurocognitive (P = 0.002) and neurologic impairment (P = 0.04), but were not protected from CD4 loss and death. Thus, the ability to generate a greater T cell proliferation response to HIV and opportunistic herpes viruses may lead to resistance to central nervous system damage, but also risk of more rapid HIV disease progression.Keywords
This publication has 53 references indexed in Scilit:
- Neurological Symptoms, Not Signs, Are Common in Early HIV InfectionJournal of Neuro-AIDS, 1996
- Common West African HLA antigens are associated with protection from severe malariaNature, 1991
- Comparison of Spinal Fluid 2-microglobulin Levels with CD4+ T Cell Count, In Vitro T Helper Cell Function, and Spinal Fluid IgG Parameters in 163 Neurologically Normal Adults Infected with the Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1991
- Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1991
- Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV, CMV+ individualsClinical and Experimental Immunology, 1990
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literatureJournal of Neurosurgery, 1985
- A study of HLA and DRw antigens in severe recurrent herpes progenitalis (HS V-2) infectionJournal of the American Academy of Dermatology, 1982
- The role of the human major histocompatibility complex in cytotoxic T-cell responses to virus-infected cellsJournal of Clinical Immunology, 1982
- Study of the HLA system in Burkitt's lymphomaHuman Immunology, 1980